Irish Life Sciences and Health Tech companies raised €491.3 million (£432 million) across 89 venture capital deals in 2024, reaching a decade-high, according to a PitchBook-powered report. Late-stage and venture-growth deals accounted for 46% of total volume, more than double the proportion recorded in 2014, reflecting a maturing ecosystem and strong investor confidence.

Cepta Duffy, Head of Life Sciences and Health Tech at Enterprise Ireland, highlighted Ireland’s performance amid global funding contractions, describing the sector as “resilient, thriving, and ready for its next phase of global leadership.” Enterprise Ireland was the world’s most active investor in 2024, participating in 60 deals, and administering the €500 million (£440 million) Disruptive Technologies Innovation Fund to support health innovation. To date, €454 million (£400 million) has been awarded, with €298 million (£262 million) directed to 68 projects in the Health and Wellbeing sector.

Momentum continued in 2025 with Dublin-based medical device firm FIRE1 securing a €115 million (£101 million) late-stage round, one of Europe’s largest Health Tech deals this year. FIRE1’s heart failure management system, Norm, uses an implanted sensor to monitor fluid levels and a patient-worn belt to transmit data to cloud-based analytics, giving medical teams real-time insights. CEO Conor Hanley emphasised empowering patients with actionable data to improve outcomes.

Ireland is Europe’s second-largest MedTech exporter after Switzerland, generating €16 billion in annual exports. The country hosts over 700 Life Sciences and Health Tech firms, including more than 400 home-grown companies and nine of the world’s top ten MedTech multinationals.

Digital transformation is advancing locally, with 31 hospitals enabling patients to access appointments and personal health data through the HSE Health App, with further rollout planned across public hospitals.

Read the full report to explore Ireland’s Life Sciences and Health Tech investment trends and market opportunities.